MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting DLC1

CONCLUSIONS: Collectively, miR-301b-3p was identified to actively function on LUAD malignant progression by suppressing DLC1 expression. This discovery provides a novel therapeutic strategy for LUAD patients, which helps improve the survival of patients.PMID:33754907 | DOI:10.1177/1533033821990036

Source: Technology in Cancer Research and Treatment - March 23, 2021 Category: Cancer & Oncology Authors: Haitao Liu Xingjie Ma Niu Niu Junjie Zhao Chao Lu Fan Yang Weibo Qi Source Type: research